Single and dual agonists The fundamental difference between these two molecules is that semaglutide is a GLP-1 agonist, i.e., it has a strong structural similarity (95%) with this hormone and specifically activates its receptor, while tirzepatide is a dual agonist, i.e., it has a hybrid structure that allows it to activate both GLP-1 and GIP receptors (Figure 2)
Many people are curious about whether insurance covers semaglutide weight loss treatments
Heres why: There have been reports of serious side effects from the salt compounds and there are no studies to show that the salt forms even work
A 2025 real-world safety comparison found the two drugs had distinct safety profiles, rather than one being safer overall
The weight loss from semaglutide comes primarily from reduced appetite and altered food preferences through central nervous system pathways, not from feeling too nauseous to eat
How to dispose of Ozempic Ozempic comes with Novofine pen needles, and you should use a new needle for each injection